Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending April 11, 2008. The document serves as a notification of transactions involving Directors, Persons Discharging Managerial Responsibility, or Connected Persons regarding their interests in the company's Ordinary shares.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is strictly a disclosure of insider share transactions and does not contain financial performance data.
Material Changes
The filing details the acquisition of Ordinary shares by six individuals through the Company's ShareReward Plan on April 10, 2008. The shares were purchased at a price of GBP 11.06 per Ordinary share under the Dividend Reinvestment element of the Plan. The specific acquisitions were:
- Mr J S Heslop: 23 shares
- Mr E J Gray: 23 shares
- Mr D Learmouth: 23 shares
- Dr D Pulman: 11 shares
- Mr C Viehbacher: 4 shares
- Mr A P Witty: 23 shares
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The document is limited to the statutory notification of the share transactions described above in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a).
Key Facts for Investor Verification
- Transaction Date: April 10, 2008
- Share Price: GBP 11.06 per Ordinary share
- Transaction Mechanism: ShareReward Plan (Dividend Reinvestment element)
- Total Shares Acquired by Disclosed Individuals: 108 shares
- Notification Date: April 11, 2008